Bioassays in natural product research - Strategies and methods in the search for anti-inflammatory and antimicrobial activity

Phytochemical Analysis

Volumn 25, Issue 1, 2014, Pages 13-28

  Strömstedt, Adam A ^a   Felth, Jenny ^a   Bohlin, Lars ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

anti inflammatory; antibacterial; antimicrobial; bioassay; cytotoxicity; liposome; membrane; natural product; peptide

Indexed keywords

BIOASSAY; CELL CULTURE; CYTOTOXICITY; LIPOSOMES; MICROORGANISMS; MOLECULES;

ANTI-INFLAMMATORIES; ANTI-INFLAMMATORY ACTIVITY; ANTI-MICROBIAL ACTIVITY; ANTIBACTERIALS; ANTIMICROBIAL; BIOACTIVE MOLECULES; MODE OF ACTION; NATURAL PRODUCTS; PRODUCT RESEARCH; RESEARCH STRATEGY;

PEPTIDES;

ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; CARDIAC GLYCOSIDE; CHOLESTEROL; CYCLOTIDE; CYTOTOXIC AGENT; DRUG METABOLITE; GAMBOGIC ACID; NATURAL PRODUCT; POLYPEPTIDE ANTIBIOTIC AGENT; PROSTAGLANDIN SYNTHASE; TRYPTOPHAN;

ADSORPTION; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTIFICIAL MEMBRANE; BACTERIAL MEMBRANE; BIOASSAY; BIOFILM; BIOFOULING; BIOLOGICAL ACTIVITY; CANCER CELL CULTURE; CELL MEMBRANE; CYTOLYSIS ASSAY; CYTOTOXICITY; ELLIPSOMETRY; ETHNOPHARMACOLOGY; FLUORESCENCE; FUNGAL MEMBRANE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NEPHRITIS; NEUTROPHIL; NONHUMAN; POISONOUS JELLYFISH; PSORIASIS; REVIEW; STRUCTURE ACTIVITY RELATION; ZETA POTENTIAL;

FUNGI;

ANTI-INFLAMMATORY; ANTIBACTERIAL; ANTIMICROBIAL; BIOASSAY; CYTOTOXICITY; LIPOSOME; MEMBRANE; NATURAL PRODUCT; PEPTIDE;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; BIOFILMS; BIOLOGICAL ASSAY; BIOLOGICAL PRODUCTS; CELL MEMBRANE; DRUG EVALUATION, PRECLINICAL; ETHNOPHARMACOLOGY; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84890561350     PISSN: 09580344     EISSN: 10991565     Source Type: Journal    
DOI: 10.1002/pca.2468     Document Type: Review

References (139)

1. Aizman O, Uhlén P, Lal M, Brismar H, Aperia A,. 2001. Ouabain, a steroid hormone that signals with slow calcium oscillations. Proc Nat Acad Sci USA 98 (23): 13420- 13424.
2. Alsmark C, Foster PG, Sicheritz-Pontén T, Nakjang S, Embley TM, Hirt RP,. 2013. Patterns of prokaryotic lateral gene transfers affecting parasitic microbial eukaryotes. Genome Biol 14 (2): DOI: 10.1186/gb-2013-14-2- r19.
3. Belas R, Manos J, Suvanasuthi R,. 2004. Proteus mirabilis ZapA metalloprotease degrades a broad spectrum of substrates, including antimicrobial peptides. Infect Immun 72 (9): 5159-5167.
4. Bergman P, Johansson L, Asp V, Plant L, Gudmundsson GH, Jonsson AB, Agerberth B,. 2005. Neisseria gonorrhoeae downregulates expression of the human antimicrobial peptide LL-37. Cell Microbiol 7 (7): 1009-1017.
5. Bohlin L,. 1993. Research on pharmacologically active natural products at the Department of Pharmacognosy, Uppsala University. J Ethnopharmacol 38 (2-3): 225-231.
6. Bohlin L, Ali Y, Sandberg F,. 1974. Screening of African Strychnos species for convulsant and muscle-relaxant effects. Acta Pharm Suec 11 (3): 233-238.
7. Bohlin L, Perera P, Vasänge M,. 1997. Bioassays using the phospholipid mediator PAF in the search for anti-inflammatory natural products. Curr Org Chem 1 (4): 345-360.
8. Boström M, Williams DRM, Ninham BW,. 2001. Surface tension of electrolytes: Specific ion effects explained by dispersion forces. Langmuir 17 (15): 4475-4478.
9. Boulanger N, Bulet P, Lowenberger C,. 2006. Antimicrobial peptides in the interactions between insects and flagellate parasites. Trends Parasitol 22 (6): 262-268.
10. Burman R, Strömstedt AA, Malmsten M, Göransson U,. 2011. Cyclotide-membrane interactions: Defining factors of membrane binding, depletion and disruption. Biochim Biophys Acta 1808 (11): 2665-2673.
11. Capon RJ,. 2010. Marine natural products chemistry: past, present, and future. Aust J Chem 63 (6): 851-854.
12. Cevc G,. 1993. Phospholipids Handbook. Marcel Dekker, Inc.: New York.
13. Chou TC, Talalay P,. 1984. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzym Regul 22: 27-55.
14. Claeson P, Bohlin L,. 1997. Some aspects of bioassay methods in natural-product research aimed at drug lead discovery. Trends Biotechnol 15 (7): 245-248.
15. Clarke JA, Heron AJ, Seddon JM, Law RV,. 2006. The diversity of the liquid ordered (LO) phase of phosphatidylcholine/cholesterol membranes: a variable temperature multinuclear solid-state NMR and x-ray diffraction study. Biophys J 90 (7): 2383-2393.
16. Colgrave ML, Craik DJ,. 2004. Thermal, chemical, and enzymatic stability of the cyclotide kalata B1: the importance of the cyclic cystine knot. Biochemistry 43 (20): 5965-5975.
17. Cragg GM, Newman DJ,. 2013. Natural products: a continuing source of novel drug leads. Biochim Biophys Acta 1830 (6): 3670-95.
18. Crawford AD, Liekens S, Kamuhabwa AR, Maes J, Munck S, Busson R, Rozenski J, Esguerra CV, de Witte PA,. 2011. Zebrafish bioassay-guided natural product discovery: isolation of angiogenesis inhibitors from East African medicinal plants. PLoS One 6 (2): e14694.
19. Davis JH, Clair JJ, Juhasz J,. 2009. Phase equilibria in DOPC/DPPC-d62/cholesterol mixtures. Biophys J 96 (2): 521-539.
20. Decker T, Lohmann-Matthes ML,. 1988. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods 115 (1): 61-69.
21. Dirsch VM, Antlsperger DSM, Hentze H, Vollmar AM,. 2002. Ajoene, an experimental anti-leukemic drug: mechanism of cell death. Leukemia 16 (1): 74-83.
22. Donlan RM, Costerton JW,. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15 (2): 167-93.
23. Dorschner RA, Pestonjamasp VK, Tamakuwala S, Ohtake T, Rudisill J, Nizet V, Agerberth B, Gudmundsson GH, Gallo RL,. 2001. Cutaneous injury induces the release of cathelicidin antimicrobial peptides active against group A Streptococcus. J Invest Dermatol 117 (1): 91-7.
24. Eftink MR,. 1991. Fluorescence techniques for studying protein structure. Methods Biochem Anal 35: 127-205.
25. Fan F, Wood KV,. 2007. Bioluminescent assays for high-throughput screening. Assay Drug Dev Technol 5 (1): 127-36.
26. Felth J,. 2011. Studies of Cytotoxic Compounds of Natural Origin and their Mechanisms of Action. Uppsala University.
27. Felth J, Rickardson L, Rosén J, Wickström M, Fryknäs M, Lindskog M, Bohlin L, Gullbo J,. 2009. Cytotoxic effects of cardiac glycosides in colon cancer cells, alone and in combination with standard chemotherapeutic drugs. J Nat Prod 72 (11): 1969-1974.
28. Felth J, Lesiak-Mieczkowska K, D'Arcy P, Haglund C, Gullbo J, Larsson R, Linder S, Bohlin L, Fryknäs M, Rickardson L,. 2012. Gambogic acid is cytotoxic to cancer cells through inhibition of the ubiquitin-proteasome system. Invest New Drugs. DOI 10.1007/s10637-012-9902-y.
29. Filippov A, Orädd G, Lindblom G,. 2003. The effect of cholesterol on the lateral diffusion of phospholipids in oriented bilayers. Biophys J 84 (5): 3079-3086.
30. Flores-Bustamante ZR, Rivera-Orduna FN, Martinez-Cardenas A, Flores-Cotera LB,. 2010. Microbial paclitaxel: advances and perspectives. J Antibiot (Tokyo) 63 (8): 460-467.
31. Frohm M, Agerberth B, Ahangari G, Ståhle-Bäckdahl M, Lidén S, Wigzell H, Gudmundsson GH,. 1997. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem 272 (24): 15258- 15263.
32. Ge Y, MacDonald DL, Holroyd KJ, Thornsberry C, Wexler H, Zasloff M,. 1999. In vitro antibacterial properties of pexiganan, an analog of magainin. Antimicrob Agents Chemother 43 (4): 782-788.
33. Giacometti A, Cirioni O, Barchiesi F, Del Prete MS, Fortuna M, Caselli F, Scalise G,. 2000. In vitro susceptibility tests for cationic peptides: Comparison of broth microdilution methods for bacteria that grow aerobically. Antimicrob Agents Ch 44 (6): 1694-1696.
34. Göransson U, Burman R, Gunasekera S, Strömstedt AA, Rosengren KJ,. 2012. Circular proteins from plants and fungi. J Biol Chem 287 (32): 27001- 27006.
35. Gran L, Sandberg F, Sletten K,. 2000. Oldenlandia affinis (R&S) DC. A plant containing uteroactive peptides used in African traditional medicine. J Ethnopharmacol 70 (3): 197-203.
36. Guina T, Yi EC, Wang H, Hackett M, Miller SI,. 2000. A PhoP-regulated outer membrane protease of Salmonella enterica serovar typhimurium promotes resistance to alpha-helical antimicrobial peptides. J Bacteriol 182 (14): 4077-4086.
37. Guoji Y, Orita M, Tashiro K, Abe H,. 1994. Effects of glycyrrhetinic acid on aminonucleoside nephrosis in rats. Naunyn Schmiedebergs Arch Pharmacol 349 (3): 318-23.
38. Hallböök H, Felth J, Eriksson A, Fryknäs M, Bohlin L, Larsson R, Gullbo J,. 2011. Ex vivo activity of cardiac glycosides in acute leukaemia. PLoS One 6 (1): e15718.
39. Halling KK, Ramstedt B, Nyström JH, Slotte JP, Nyholm TK,. 2008. Cholesterol interactions with fluid-phase phospholipids: effect on the lateral organization of the bilayer. Biophys J 95 (8): 3861-3871.
40. Hancock RE, Sahl HG,. 2006. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24 (12): 1551-1557.
41. Hedner E, Sjögren M, Frändberg PA, Johansson T, Göransson U, Dahlström M, Jonsson P, Nyberg F, Bohlin L,. 2006. Brominated cyclodipeptides from the marine sponge Geodia barretti as selective 5-HT ligands. J Nat Prod 69 (10): 1421-1424.
42. Heilborn JD, Nilsson MF, Kratz G, Weber G, Sørensen O, Borregaard N, Ståhle-Bäckdahl M,. 2003. The cathelicidin antimicrobial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J Invest Dermatol 120 (3): 379-389.
43. Henriksen J, Rowat AC, Ipsen JH,. 2004. Vesicle fluctuation analysis of the effects of sterols on membrane bending rigidity. Eur Biophys J 33 (8): 732-741.
44. Henriques ST, Huang YH, Castanho MA, Bagatolli LA, Sonza S, Tachedjian G, Daly NL, Craik DJ,. 2012. Phosphatidylethanolamine binding is a conserved feature of cyclotide-membrane interactions. J Biol Chem 287 (40): 33629- 33643.
45. Hoskin DW, Ramamoorthy A,. 2008. Studies on anticancer activities of antimicrobial peptides. Biochim Biophys Acta 1778 (2): 357-375.
46. Huss U, Ringbom T, Perera P, Bohlin L, Vasänge M,. 2002. Screening of ubiquitous plant constituents for COX-2 inhibition with a scintillation proximity based assay. J Nat Prod 65 (11): 1517-1521.
47. Ireland DC, Colgrave ML, Craik DJ,. 2006. A novel suite of cyclotides from Viola odorata: sequence variation and the implications for structure, function and stability. Biochem J 400 (1): 1-12.
48. Islam D, Bandholtz L, Nilsson J, Wigzell H, Christensson B, Agerberth B, Gudmundsson G,. 2001. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med 7 (2): 180-185.
49. Johansson S, Lindholm P, Gullbo J, Larsson R, Bohlin L, Claeson P,. 2001. Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells. Anticancer Drugs 12 (5): 475-483.
50. Johansson S, Göransson U, Luijendijk T, Backlund A, Claeson P, Bohlin L,. 2002. A neutrophil multitarget functional bioassay to detect anti-inflammatory natural products. J Nat Prod 65 (1): 32-41.
51. Karlsson PC, Huss U, Jenner A, Halliwell B, Bohlin L, Rafter JJ,. 2005. Human fecal water inhibits COX-2 in colonic HT-29 cells: role of phenolic compounds. J Nutr 135 (10): 2343-2349.
52. Kawamura A, Brekman A, Grigoryev Y, Hasson TH, Takaoka A, Wolfe S, Soll CE,. 2006. Rediscovery of natural products using genomic tools. Bioorg Med Chem Lett 16 (11): 2846-2849.
53. Kennedy CA, O'Gara JP,. 2004. Contribution of culture media and chemical properties of polystyrene tissue culture plates to biofilm development by Staphylococcus aureus. J Med Microbiol 53 (11): 1171-1173.
54. Klotman ME, Chang TL,. 2006. Defensins in innate antiviral immunity. Nat Rev Immunol 6 (6): 447-456.
55. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN, Reich M, Hieronymus H, Wei G, Armstrong SA, Haggarty SJ, Clemons PA, Wei R, Carr SA, Lander ES, Golub TR,. 2006. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313 (5795): 1929- 1935.
56. Landini P, Antoniani D, Burgess JG, Nijland R,. 2010. Molecular mechanisms of compounds affecting bacterial biofilm formation and dispersal. Appl Microbiol Biotechnol 86 (3): 813-823.
57. Lange Y, Dolde J, Steck TL,. 1981. The rate of transmembrane movement of cholesterol in the human erythrocyte. J Biol Chem 256 (11): 5321-5323.
58. Larsson J, Gottfries J, Muresan S, Backlund A,. 2007. ChemGPS-NP: tuned for navigation in biologically relevant chemical space. J Nat Prod 70 (5): 789-794.
59. Lindhagen E, Nygren P, Larsson R,. 2008. The fluorometric microculture cytotoxicity assay. Nat Protoc 3 (8): 1364-1369.
60. Lindholm P, Göransson U, Johansson S, Claeson P, Gullbo J, Larsson R, Bohlin L, Backlund A,. 2002. Cyclotides: a novel type of cytotoxic agents. Mol Cancer Ther 1 (6): 365-369.
61. Liu YJ, Vieira E, Gylfe E,. 2004. A store-operated mechanism determines the activity of the electrically excitable glucagon-secreting pancreatic alpha-cell. Cell Calcium 35 (4): 357-365.
62. Lopez-Lazaro M,. 2007. Digitoxin as an anticancer agent with selectivity for cancer cells: possible mechanisms involved. Expert Opin Ther Targets 11: 1043-1053.
63. Lotte K, Plessow R, Brockhinke A,. 2004. Static and time-resolved fluorescence investigations of tryptophan analogues - a solvent study. Photochem Photobiol Sci 3 (4): 348-359.
64. Lu H, Ouyang W, Huang C,. 2006. Inflammation, a key event in cancer development. Mol Cancer Res 4 (4): 221-233.
65. Lugtenberg EJ, Peters R,. 1976. Distribution of lipids in cytoplasmic and outer membranes of Escherichia coli K12. Biochim Biophys Acta 441 (1): 38-47.
66. Makino K, Yamada T, Kimura M, Oka T, Ohshima H, Kondo T,. 1991. Temperature- and ionic strength-induced conformational changes in the lipid head group region of liposomes as suggested by zeta potential data. Biophys Chem 41 (2): 175-183.
67. Malone MH, Robichau RC,. 1962. A hippocratic screen for pure or crude drug materials. Lloydia 25 (4): 320-322.
68. Mishra BB, Tiwari VK,. 2011. Natural products: an evolving role in future drug discovery. Eur J Med Chem 46 (10): 4769-807.
69. Mosmann T,. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65 (1-2): 55-63.
70. Needham D, Nunn RS,. 1990. Elastic deformation and failure of lipid bilayer membranes containing cholesterol. Biophys J 58 (4): 997-1009.
71. Nevin KP, Kim BC, Glaven RH, Johnson JP, Woodard TL, Methé BA, Didonato RJ, Covalla SF, Franks AE, Liu A, Lovley DR,. 2009. Anode biofilm transcriptomics reveals outer surface components essential for high density current production in Geobacter sulfurreducens fuel cells. PLoS One 4 (5): e5628.
72. Nishimura S, Tsurumoto T, Yonekura A, Adachi K, Shindo H,. 2006. Antimicrobial susceptibility of Staphylococcus aureus and Staphylococcus epidermidis biofilms isolated from infected total hip arthroplasty cases. J Orthop Sci 11 (1): 46-50.
73. Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill J, Dorschner RA, Pestonjamasp V, Piraino J, Huttner K, Gallo RL,. 2001. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414 (6862): 454-457.
74. Noreen Y, Ringbom T, Perera P, Danielson H, Bohlin L,. 1998. Development of a radiochemical cyclooxygenase-1 and -2 in vitro assay for identification of natural products as inhibitors of prostaglandin biosynthesis. J Nat Prod 61 (1): 2-7.
75. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DY,. 2002. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347 (15): 1151-60.
76. Oppenheim JJ, Biragyn A, Kwak LW, Yang D,. 2003. Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Ann Rheum Dis 62: 17-21.
77. Overhage J, Campisano A, Bains M, Torfs EC, Rehm BH, Hancock RE,. 2008. Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect Immun 76 (9): 4176-4182.
78. Ozaki K, Leonard WJ,. 2002. Cytokine and cytokine receptor pleiotropy and redundancy. J Biol Chem 277 (33): 29355- 8.
79. Pairet M, van Ryn J,. 1998. Experimental models used to investigate the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2 by non-steroidal anti-inflammatory drugs. Inflamm Res 47 Suppl 2: S93-S101.
80. Perera P, Ringbom T, Huss U, Vasänge M, Bohlin L,. 2001. Search for natural products which affect cyclooxygenase-2. In Bioactive Compounds from Natural Sources, Tringali C, (ed.). Taylor and Francis: London; 433-472.
81. Perne A, Muellner MK, Steinrueck M, Craig-Mueller N, Mayerhofer J, Schwarzinger I, Sloane M, Uras IZ, Hoermann G, Nijman SM, Mayerhofer M,. 2009. Cardiac glycosides induce cell death in human cells by inhibiting general protein synthesis. PLoS One 4 (12): e8292.
82. Perron GG, Zasloff M, Bell G,. 2006. Experimental evolution of resistance to an antimicrobial peptide. Proc Biol Sci 273 (1583): 251-256.
83. Pettersson J, Karlsson PC, Choi YH, Verpoorte R, Rafter JJ, Bohlin L,. 2008. NMR metabolomic analysis of fecal water from subjects on a vegetarian diet. Biol Pharm Bull 31 (6): 1192-1198.
84. Pongprayoon U, Bohlin L, Wasuwat S,. 1991. Neutralization of toxic effects of different crude jellyfish venoms by an extract of Ipomoea pes-caprae (L.) R. Br. J Ethnopharmacol 35 (1): 65-69.
85. Pongprayoon U, Baeckström P, Jacobsson U, Lindström M, Bohlin L,. 1992. Antispasmodic activity of beta-damascenone and E-phytol isolated from Ipomoea pes-caprae. Planta Med 58 (1): 19-21.
86. Pränting M, Lööv C, Burman R, Göransson U, Andersson DI,. 2010. The cyclotide cycloviolacin O2 from Viola odorata has potent bactericidal activity against Gram-negative bacteria. J Antimicrob Chemoth 65 (9): 1964-1971.
87. Putsep K, Carlsson G, Boman HG, Andersson M,. 2002. Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 360 (9340): 1144-1149.
88. Rao XJ, Yu XQ,. 2010. Lipoteichoic acid and lipopolysaccharide can activate antimicrobial peptide expression in the tobacco hornworm Manduca sexta. Dev Comp Immunol 34 (10): 1119-1128.
89. Riedl S, Zweytick D, Lohner K,. 2011. Membrane-active host defense peptides - challenges and perspectives for the development of novel anticancer drugs. Chem Phys Lipids 164 (8): 766-781.
90. Rietveld AG, Killian JA, Dowhan W, de Kruijff B,. 1993. Polymorphic regulation of membrane phospholipid composition in Escherichia coli. J Biol Chem 268 (17): 12427- 12433.
91. Rolfsen W, Bohlin L, Yeboah SK, Geevaratne M, Verpoorte R,. 1978. New indole alkaloids of Strychnos dale and Strychnos elaeocarpa. Planta Med 34 (3): 264-273.
92. Rosén J, Richardsson U, Backlund A, Gullbo A, Bohlin L, Larsson R, Gottfries J,. 2009. ChemGPS-NP Mapping of Chemical Compounds for Prediction of Anticancer Mode of Action. QSAR and Combinatorial Science 28 (4): 436-446.
93. Roy MT, Gallardo M, Estelrich J,. 1998. Influence of size on electrokinetic behavior of phosphatidylserine and phosphatidylethanolamine lipid vesicles. J Colloid Interface Sci 206 (2): 512-517.
94. Ruissen AL, Groenink J, Krijtenberg P, Walgreen-Weterings E, van't Hof W, Veerman EC, Nieuw Amerongen AV,. 2003. Internalisation and degradation of histatin 5 by Candida albicans. Biol Chem 384 (1): 183-190.
95. Salzman NH, Chou MM, de Jong H, Liu L, Porter EM, Paterson Y,. 2003. Enteric salmonella infection inhibits Paneth cell antimicrobial peptide expression. Infect Immun 71 (3): 1109-1115.
96. Samuelsson G,. 1991. Bioassay-guided isolation of pharmacologically active compounds: Experences from studies on plants used in traditional medicine. Rev Latinoamer Quím 22 (1): 41-45.
97. Samuelsson G, Kyerematen G, Farah MH,. 1985. Preliminary chemical characterization of pharmacologically active compounds in aqueous plant extracts. J Ethnopharmacol 14 (2-3): 193-201.
98. Sandberg F,. 1967. Pharmacological screening of medicinal plants. Proc Int Symp Medicinal Plants Government Press, Colombo, Ceylon; 187-201.
99. Schmidtchen A, Frick IM, Andersson E, Tapper H, Björck L,. 2002. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol Microbiol 46 (1): 157-168.
100. Sieprawska-Lupa M, Mydel P, Krawczyk K, Wojcik K, Puklo M, Lupa B, Suder P, Silberring J, Reed M, Pohl J, Shafer W, McAleese F, Foster T, Travis J, Potempa J,. 2004. Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother 48 (12): 4673-4679.
101. Sjögren M, Göransson U, Johnson AL, Dahlström M, Andersson R, Bergman J, Jonsson PR, Bohlin L,. 2004. Antifouling activity of brominated cyclopeptides from the marine sponge Geodia barretti. J Nat Prod 67 (3): 368-372.
102. Sjögren M, Jonsson PR, Dahlström M, Lundälv T, Burman R, Göransson U, Bohlin L,. 2011. Two brominated cyclic dipeptides released by the coldwater marine sponge Geodia barretti act in synergy as chemical defense. J Nat Prod 74 (3): 449-454.
103. Skogman ME, Vuorela PM, Fallarero A,. 2012. Combining biofilm matrix measurements with biomass and viability assays in susceptibility assessments of antimicrobials against Staphylococcus aureus biofilms. J Antibiot (Tokyo) 65 (9): 453-459.
104. Smaby JM, Momsen MM, Brockman HL, Brown RE,. 1997. Phosphatidylcholine acyl unsaturation modulates the decrease in interfacial elasticity induced by cholesterol. Biophys J 73 (3): 1492-1505.
105. Smoluchowski Mv,. 1903. Contribution à la théorie de l'endosmose électrique et de quelques phenomènes corrélatifs. Bull Intren Acad Sci Cracovie 8: 182-200.
106. Soni KA, Balasubramanian AK, Beskok A, Pillai SD,. 2008. Zeta potential of selected bacteria in drinking water when dead, starved, or exposed to minimal and rich culture media. Curr Microbiol 56 (1): 93-97.
107. Soto AM, Justicia H, Wray JW, Sonnenschein C,. 1991. p-Nonyl-phenol: an estrogenic xenobiotic released from ' modified ' polystyrene. Environ Heal Perspect 92: 167-173.
108. Stafford JH, Thorpe PE,. 2011. Increased exposure of phosphatidylethanolamine on the surface of tumor vascular endothelium. Neoplasia 13 (4): 299-308.
109. Steinberger RE, Holden PA,. 2005. Extracellular DNA in single- and multiple-species unsaturated biofilms. Appl Environ Microbiol 71 (9): 5404-5410.
110. Steinstraesser L, Koehler T, Jacobsen F, Daigeler A, Goertz O, Langer S, Kesting M, Steinau H, Eriksson E, Hirsch T,. 2008. Host defense peptides in wound healing. Mol Med 14 (7-8): 528-537.
111. Stenholm A, Göransson U, Bohlin L,. 2013. Bioassay-guided Supercritical Fluid Extraction of Cyclooxygenase-2 Inhibiting Substances in Plantago major L. Phytochem Anal 24 (2): 176-183.
112. Strömstedt AA, Wessman P, Ringstad L, Edwards K, Malmsten M,. 2007. Effect of lipid headgroup composition on the interaction between melittin and lipid bilayers. J Colloid Interface Sci 311 (1): 59-69.
113. Strömstedt AA, Pasupuleti M, Schmidtchen A, Malmsten M,. 2009a. Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL-37. Antimicrob. Agents Chemother. 53 (2): 593-602.
114. Strömstedt AA, Pasupuleti M, Schmidtchen A, Malmsten M,. 2009b. Oligotryptophan-tagged antimicrobial peptides and the role of the cationic sequence. Biochim. Biophys. Acta 1788 (9): 1916-1923.
115. Strömstedt AA, Ringstad L, Schmidtchen A, Malmsten M,. 2010. Interaction between amphiphilic peptides and phospholipid membranes. Curr Opin Colloid Interface Sci 15 (6): 467-478.
116. Sunthonplain P, Wasuwat S,. 1985. Jellyfish dermatitis treated with extract of Ipomoea pes-caprae. Siriraj Hosp Gaz 37: 329-338.
117. Tenover FC, McDougal LK, Goering RV, Killgore G, Projan SJ, Patel JB, Dunman PM,. 2006. Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J Clin Microbiol 44 (1): 108-118.
118. Terzic J, Grivennikov S, Karin E, Karin M,. 2010. Inflammation and colon cancer. Gastroenterology 138 (6): 2101-2114.
119. Thewalt J, Kitson N, Araujo C, MacKay A, Bloom M,. 1992. Models of stratum corneum intercellular membranes: the sphingolipid headgroup is a determinant of phase behavior in mixed lipid dispersions. Biochem Biophys Res Commun 188 (3): 1247-1252.
120. Tote K, Horemans T, Vanden Berghe D, Maes L, Cos P,. 2010. Inhibitory effect of biocides on the viable masses and matrices of Staphylococcus aureus and Pseudomonas aeruginosa biofilms. Appl Environ Microbiol 76 (10): 3135-3142.
121. Tulp M, Bohlin L,. 2005. Rediscovery of known natural compounds: nuisance or goldmine? Bioorg Med Chem 13 (17): 5274-82.
122. Tunõn H, Bohlin L, Öjteg G,. 1994. The effect of Menyanthes trifoliata L. on acute renal failure might be due to PAF-inhibition. Phytomedicine 1 (1): 39-45.
123. Tunõn H, Olavsdotter C, Bohlin L,. 1995. Evaluation of anti-inflammatory activity of some Swedish medicinal plants. Inhibition of prostaglandin biosynthesis and PAF-induced exocytosis. J Ethnopharmacol 48 (2): 61-76.
124. Tuominen M, Bohlin L, Lindbom LO, Rolfsen W,. 1991. Enhancing effect of calaguala on the prevention of rejection on skin transplants in mice. Phytother Res 5 (5): 234-236.
125. Tydell CC, Yuan J, Tran P, Selsted ME,. 2006. Bovine peptidoglycan recognition protein-S: antimicrobial activity, localization, secretion, and binding properties. J Immunol 176 (2): 1154-1162.
126. Utsugi T, Schroit AJ, Connor J, Bucana CD, Fidler IJ,. 1991. Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes. Cancer Res 51 (11): 3062-3066.
127. Vasänge M, Rolfsen W, Bohlin L,. 1997. A sulphonoglycolipid from the fern Polypodium decumanum and its effect on the platelet activating-factor receptor in human neutrophils. J Pharm Pharmacol 49 (5): 562-566.
128. Vendramini-Costa DB, Carvalho JE,. 2012. Molecular link mechanisms between inflammation and cancer. Curr Pharm Des 18 (26): 3831-3852.
129. Vieira E, Salehi A, Gylfe E,. 2007. Glucose inhibits glucagon secretion by a direct effect on mouse pancreatic alpha cells. Diabetologia 50 (2): 370-379.
130. Villa FA, Gerwick L,. 2010. Marine natural product drug discovery: Leads for treatment of inflammation, cancer, infections, and neurological disorders. Immunopharmacol Immunotoxicol 32 (2): 228-237.
131. Vist MR, Davis JH,. 1990. Phase equilibria of cholesterol/ dipalmitoylphosphatidylcholine mixtures: 2H nuclear magnetic resonance and differential scanning calorimetry. Biochemistry 29 (2): 451-464.
132. Vivian JT, Callis PR,. 2001. Mechanisms of tryptophan fluorescence shifts in proteins. Biophys J 80 (5): 2093-2109.
133. Wehkamp J, Stange EF,. 2006. A new look at Crohn's disease: breakdown of the mucosal antibacterial defense. Ann N Y Acad Sci 1072: 321-331.
134. Wessman P, Strömstedt AA, Malmsten M, Edwards K,. 2008. Melittin-lipid bilayer interactions and the role of cholesterol. Biophys J 95 (9): 4324-4336.
135. White HL, Glassman AT,. 1974. A simple radiochemical assay for prostaglandin synthetase. Prostaglandins 7 (2): 123-129.
136. Wu Z, Xie L, Xia G, Zhang J, Nie Y, Hu J, Wang S, Zhang R,. 2005. A new tetrodotoxin-producing actinomycete, Nocardiopsis dassonvillei, isolated from the ovaries of puffer fish Fugu rubripes. Toxicon 45 (7): 851-859.
137. Yeagle P,. 1993. The Membranes of Cells. Academic Press, Inc.: San Diego.
138. Yeaman MR, Yount NY,. 2003. Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev 55 (1): 27-55.
139. Yeshak MY, Göransson U, Burman R, Hellman B,. 2012. Genotoxicity and cellular uptake of cyclotides: evidence for multiple modes of action. Mutat Res 747 (2): 176-181.